Career
Barry defends clients such as global pharmaceutical, medical device, and health care companies in complex litigation, government investigations, and enforcement matters. Clients seek his thorough risk management counseling at every stage of the product life cycle.
Barry represents clients ranging from multinational companies to early-stage start-ups in the health sciences and chemical manufacturing sectors. He helps clients to effectively confront risks such as multidistrict litigation, attorney general investigations, and other civil and criminal actions involving health care fraud and abuse. Barry also advises clients on the regulatory, compliance, and potential litigation risks as they launch new products and services and utilize emerging technologies, such as artificial intelligence.
Barry has significant experience in most state and federal courts throughout the U.S. and defends several of the largest global pharmaceutical and medical device companies in cases involving product liability and tort claims. With experience handling multiple litigations in Philadelphia County, he serves as lead counsel in a mass tort litigation and as a liaison counsel in a matter in the Philadelphia Mass Tort Program.
Barry is a frequent writer and speaker on matters affecting the life sciences industry, including litigation prevention, regulatory compliance, and settlement strategies. He is also a regular contributor to Regulatory Oversight, the firm’s podcast that discusses the latest regulatory developments.
Professional Memberships
Barry is an active member of several organizations dedicated to the causes of his clients, including the Defense Research Institute and Lawyers for Civil Justice. He also is a fellow of the American Bar Foundation.
Personal
Barry is passionate about helping cancer patients, and is a founding Board member of Ride Hard Breathe Easy, a nonprofit dedicated to ending the suffering and stigma of lung cancer patients. Through biking and other events, Ride Hard funds innovation and assists lung cancer patients with the most basic needs that interfere with proper care and treatment.
